Bioventus (BVS) Shares Outstanding (2021 - 2026)

Bioventus (BVS) has reported Shares Outstanding (Entity) for 6 consecutive years, with $84.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 1.6% year-over-year to $84.0 million; the trailing twelve-month figure through Jun 2026 stood at $84.0 million (up 1.6% YoY), and the FY2025 full-year result was $82.9 million, up 1.64% from the prior year.
• Shares Outstanding (Entity) climbed to $84.0 million in Q2 2026 per BVS's latest filing, from $83.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $84.0 million in Q2 2026 and bottomed at $77.1 million in Q2 2022.
• Historically, Shares Outstanding (Entity) has averaged $80.3 million across 5 years, with a median of $80.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) surged 36.36% in 2022, then gained 1.48% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $77.8 million in 2022, then climbed by 1.55% to $79.1 million in 2023, then climbed by 3.15% to $81.5 million in 2024, then grew by 1.64% to $82.9 million in 2025, then advanced by 1.34% to $84.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $84.0 million, $83.4 million, and $82.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.